We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
MicroRNA-139-5P inhibits human prostate cancer cell proliferation by targeting Notch1.
- Authors
Sun, Qian; Weng, Danhui; Li, Kezhen; Li, Shuang; Bai, Xiangyang; Fang, Can; Luo, Danfeng; Wu, Peng; Chen, Gang; Wei, Juncheng
- Abstract
Despite an improvement in the efficacy of chemotherapeutic agents, the outcome of patients with prostate cancer remains poor. MicroRNA (miRNA/miR)-139 expression is often downregulated in multiple types of tumor, including in prostate cancer. The aim of the present study was to investigate the inhibitory effect of miR-139 on the PC-3, C4-2B and LNCaP prostate cancer cell lines. Analysis of the cell cycle of PC-3, C4-2B and LNCaP cells transfected with miR-139 revealed a significantly increased percentage of cells in the G1 phase and a decreased percentage in the S and G2 phases compared with those transfected with a negative control miRNA. The growth inhibitory rate of miR-139-transfected cells 24, 48 and 72 h after transfection were 32.83±2.61, 52.58±3.2 and 62.36±4.55% in PC-3 cells; 30.28±2.25, 51.74±3.27 and 60.80±3.58% in C4-2B cells; and 33.20±2.67, 51.83±3.59 and 61.79±4.85% in LNCaP cells, respectively. The present study revealed that miR-139 inhibited the proliferation of prostate cancer cells by interfering with the cell cycle. Further study into the mechanism by which this happened suggested that miR-139 reduced cyclin D1 expression and inhibited cell proliferation through targeting Notch1.
- Subjects
CANCER chemotherapy; MICRORNA; PROSTATE cancer; TUMORS; CELL proliferation
- Publication
Oncology Letters, 2018, Vol 16, Issue 1, p793
- ISSN
1792-1074
- Publication type
Article
- DOI
10.3892/ol.2018.8773